Merck Sharp & Dohme LLC vs Halozyme, Inc. et al.

Patent Owner's Waiver of Patent Owner Preliminary Response

Patent Owner's Discretionary Denial Brief

EX2001 - Triggs-Raine Declaration

EX2002 - Triggs-Raine CV

EX2003 - Disclaimer

EX2004 - Sequence Listing

EX2005 - 2023 Pharma 50

EX2006 - Merck Financial Results

EX2007 - Merck Market Cap Nasdaq

EX2008 - Halozyme Market Cap Nasdaq

EX2009 - Halozyme News Revenue

EX2010 - Halozyme - Commercial Products

EX2011 - Halozyme - About Us

EX2012 - District Court Complaint

EX2013 - Alteogen announces amendment to license agreement with MSD

EX2014 - Big Pharma Business Model Report

EX2015 - CNN Medicare Article

EX2016 - White House Fact Sheet

EX2017 - Big Pharma Earnings Watch

Patent Owner's Updated Power of Attorney

Patent Owner's Updated Mandatory Notices

Patent Owner's Updated Mandatory Notices

Petitioner's Updated Mandatory Notices

Patent Owner's Updated Power of Attorney

Patent Owner's Updated Mandatory Notices

Notice: Notice filing date accorded

Patent Owner's Power of Attorney

Patent Owner's Mandatory Notices

U.S. Patent No. 12,077,791

File History of US Patent No. 12,077,791 Part 1

File History of US Patent No. 12,077,791 Part 2

File History of US Patent No. 12,077,791 Part 3

U.S. Patent No. 7,767,429

Chao, Structure of Human Hyaluronidase-1 (2007)

WO/2010/077297, published July 8, 2010

Stern, The Hyaluronidases: Their Genomics, Structures, & Mechanisms (2006)

Jedzrejas, Structures of Vertebrate Hyaluronidases (2005)

Zhang, Hyaluronidase Activity of Human Hyal1 (2009)

Arming, In vitro Mutagenesis of PH-20 Hyaluronidase from Human Sperm (1997)

Bordoli, Protein Structure Homology Modeling Using SWISSMODEL (2008)

Frost, Recombinant Human Hyaluronidase (rHuPH20) (2007)

Branden & Tooze, Introduction to Protein Structure (1999) Part 1

Branden & Tooze, Introduction to Protein Structure (1999) Part 2

Table Associating ’791 Patent to Corresponding ’731 Application

Steipe, Consensus-Based Engineering of Protein Stability (2004)

Green, Computer Graphics, Homology Modeling, and Bioinformatics (2010)

Chica, Semi-rational Approaches to Engineering Enzyme Activity (2005)

Hardy, Assessment of Contraceptive Vaccines Based on Recombinant Mouse

Pomering, Restricted Entry of IgG (2002)

Baba, Mouse Sperm Lacking Cell Surface Hyaluronidase PH-20 (2002)

Primakoff, Reversible Contraceptive Effect of PH-20 Immunization (1997)

Tung, Mechanism of Infertility in Male Guinea Pigs Immunized with Sperm

Rosengren, Recombinant Human PH20 (2018)

U.S. Patent No. 9,447,401

U.S. Patent Application No. 13/694,731

2024 Chemistry Nobel Prize Background

Gmachl, The Human Sperm Protein PH-20 Has Hyaluronidase Activity (1993)

Sills, "Retraction," Science, 319:569 (2008)

Yue, Loss of Protein Structure Stability as a Major Causative Factor (2005)

Wang & Moult, SNPs, Protein Structure, and Disease (2001)

Marković-Housley, Crystal Structure of Hyaluronidase (2000)

"Negative Results," Nature: Editorials, 453:258 (2008)

Lins, Analysis of Accessible Surface of Residues in Proteins (2003)

Hayden, Chemistry: Designer Debacle (2008)

Benkert, Toward the Estimation of the Absolute Quality (2010)

Schwede, SWISS-MODEL: An Automated Protein Homology-Modeling Server (2003)

Alberts, Molecular Biology of the Cell, Chapter 3 (2007)

He, NMR Structures of Two Designed Proteins with High Sequence Identity

Alexander, A Minimal Sequence Code for Switching Protein Structure (2009)

Ruan, Design & Characterization of a Protein Fold Switching Network (2023)

Sievers, Fast, Scalable Generation of High-Quality Protein (2011)

Mihel, PSAIA – Protein Structure and Interaction Analyzer (2008)

Redline Comparison of the ’731 and ’791 Specifications

Beasley & Hecht, Protein Design: The Choice of de Novo Sequences (1997)

Xiong, Periodicity of Polar and Nonpolar Amino Acids (1995)

Hayden, Key Protein-Design Papers Challenged (2009)

KEGG, DRUG: Hyaluronidase (human recombinant)

Pace & Scholtz, A Helix Propensity Scale (1998)

U.S. Patent Application No. 61/631,313

U.S. Patent Application No. 61/796,208

Hom_pre2011

Hom_pre2011_header

Hom_pre2011_header_clean

Hom_pre2011.fasta

Ph20_pre2011.aln-clustal_num

Ph20_pre2011 Alignment html

Leisola & Turunen, Protein Engineering: Opportunities and Challenges (2007)

Hecht, De Novo Proteins from Designed Combinatorial Libraries (2004)

Rosengren, Clinical Immunogenicity of rHuPH20 (2015)

Collection of BLAST Webpages from the Internet Archive

Collection of Clustal Omega Webpages from the Internet Archive

Collection of SWISS-MODEL Webpages from the Internet Archive

Collection of PyMol Webpages from the Internet Archive

Swiss Model Printout of PH20 Model

Swiss Model Printout of PH20 Model with I309N Mutation

Swiss Model Printout of PH20 Model with I309L Mutation

Swiss Model Printout of PH20 Model with I309M Mutation

Hunnicutt, Sperm Surface Protein PH-20 Is Bifunctional (1996)

Bookbinder, A Recombinant Human Enzyme for Enhanced Interstitial...(2006)

Goldberg, “Protein degradation and protection of against misfolded...(2003)

Declaration of Jeffrey P. Kushan

Declaration of Dr. Michael Hecht

Declaration of Dr. Sheldon Park

Petition for Post Grant Review of U.S. Patent No. 12,077,791

Petitioner's Power of Attorney